m's intention to explore strategic
alternatives, to seek a buyer for the business or assets of iFire, and to
monetize non-core assets. Westaim disclaims any intention or obligation to
revise forward-looking statements whether as a result of new information,
future developments or otherwise. Accordingly, readers are advised not to
place undue reliance on forward-looking statements, and should not rely on
this information at any date other than the date of this news release. All
forward-looking statements are expressly qualified in their entirety by
this cautionary statement.
THE WESTAIM CORPORATION
Financial Highlights
(unaudited)
(thousands of dollars except per share data)
-------------------------------------------------------------------------
Three Months Ended Twelve Months Ended
December 31 December 31
--------------------- ---------------------
Consolidated Statements of
Operations 2007 2006 2007 2006
-------------------------------------------------------------------------
Revenue $ 11,174 $ 5,140 $ 31,830 $ 27,591
Income (loss) from continuing
operations 1,169 (2,200) (2,830) (12,861)
Net loss (26,807) (11,019) (58,033) (50,557)
Net income (loss) per common
share - basic and diluted
Continuing operations 0.01 (0.02) (0.03) (0.14)
Net loss (0.28) (0.12) (0.62) (0.54)
Weighted average number of
common shares outstanding
(thousands) 94,136 93,797 94,070 93,523
-------------------------------------------------------------------------
Three
'/>"/>
SOURCE Westaim Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 Related medicine news :1.
Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results2.
Westaim reduces ABCP exposure3.
Westaim announces 2007 third quarter results4.
Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results5.
The Westaim Corporation update on status of short-term investments6.
Abbott Announces 10.8 Percent Increase in Quarterly Dividend7.
China Holdings Announces Starwood Research Institute Initiates Research Coverage8.
Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Have Been Filed Against American Dental Partners, Inc.9.
Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation10.
Nerites Corporation Announces Closing of Series A Funding Round11.
Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding